Actos Bladder Cancer Attorneys
Pioglitazone Hydrochloride, also known as Actos, is an anti-diabetic medication. Actos is intended to be used along with proper diet to control adult onset diabetes (diabetes II). Actos regulates the blood glucose and reduces insulin resistance.
Those who took Actos and subsequently received a diagnosis of bladder cancer may be entitled to have an Actos bladder cancer lawsuit filed on their behalf. The FDA has made a public safety alert stating there is a correlation between taking Actos and the diagnosis of bladder cancer. This alert stated that those who took Actos for over a year face a possible higher risk of a bladder cancer diagnosis. It is alleged the manufacturer of Actos may have not properly warned those prescribed Actos of the associated bladder cancer risk.
Actos and Bladder Cancer Symptoms
The most common symptom associated with bladder cancer is blood in the urine. Those suffering from bladder cancer may see their urine change color, resulting in a bright red, dark brownish or dark yellow hue. Just because no discernible color changes may be noted in your urine, do not assume all is well if you have taken Actos and suffer from:
- Frequent urination
- Inability to successfully urinate
- Recurrent urinary tract infections
If you suffer from any of these symptoms, please get checked immediately by your physician.
Link between Actos and Bladder Cancer
The FDA issued a June 15, 2011, safety announcement with respect to the link between Actos and bladder cancer. Upon data review from a 5 year study done by the manufacturer of Actos, the FDA issued a strong public alert. This public notification stated the longer one was prescribed Actos; a greater chance existed to for them to develop bladder cancer. This manufacturer study determined patients who took the drug Actos over a year faced a 40% increased risk of being diagnosed with bladder cancer.
As a result of the link made by the Actos manufacturer study, the FDA recommended against Actos being prescribed to those with bladder cancer as well as being prescribed only with great caution to those with a history of bladder cancer. Upon review of the study, the FDA went further to require the manufacturer to change its drug label and medication guide to reflect this information.
Although the United States has not formally recalled Actos, Germany and France have limited its use in those countries. Germany and France based their recall on a similar French investigational study which also showed an increased risk of bladder cancer with the use of Actos.
Contact an Actos Bladder Cancer Lawyer
The attorneys at the Kelley BerneheimDolinsky, LLC are currently prosecuting Actos bladder cancer claims, as many patients who were diagnosed with Actos bladder cancer were not aware of the serious risks associated with this product. If you were diagnosed with bladder cancer after taking the diabetes drug Actos, you may be entitled to significant compensation. For more information on Actos bladder cancerclaims, contact an attorney for a review of your case at no cost to you. 1-800-849-8072.